EIF4EBP1 and neuroblastoma: On the other hand, Kaplan–Meier survival estimates in high-risk NB patients (SEQC cohort) revealed that high EIF4EBP1 levels were correlated with poor overall survival (p = 7.4e-03, Fig. 2f), as well as with reduced event-free survival (supplementary Fig. 1f), suggesting that EIF4EBP1 expression can stratify patients within the most aggressive NB subset.